Cyfuse Biomedical K.K. (TYO:4892)
Japan flag Japan · Delayed Price · Currency is JPY
492.00
-11.00 (-2.19%)
Nov 18, 2026, 10:49 AM JST

Cyfuse Biomedical K.K. Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,0773,7263,0523,8734,4372,413
Cash & Short-Term Investments
3,0773,7263,0523,8734,4372,413
Cash Growth
-17.77%22.08%-21.20%-12.71%83.88%16.46%
Accounts Receivable
5520171357
Other Receivables
2240433256-
Receivables
274563496957
Inventory
738855464061
Prepaid Expenses
71725116175
Other Current Assets
53193222
Total Current Assets
3,2533,9343,2403,9874,5652,558
Property, Plant & Equipment
13715514116918927
Long-Term Investments
207173131535555
Other Intangible Assets
234454
Other Long-Term Assets
212112
Total Assets
3,6014,2663,5184,2144,8152,646

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
-6915248
Accrued Expenses
5121619256
Short-Term Debt
315485507550467128
Current Portion of Long-Term Debt
47118418187772
Current Portion of Leases
-----8
Current Income Taxes Payable
406359477474
Current Unearned Revenue
--20192219
Other Current Liabilities
505313111371
Total Current Liabilities
881866648666682386
Long-Term Debt
300642327345363359
Other Long-Term Liabilities
121111
Total Liabilities
1,1821,5109761,0121,046746

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,9651,8281,3641,2831,272100
Additional Paid-In Capital
4,5874,4503,9863,9053,8932,721
Retained Earnings
-4,272-3,622-2,858-1,986-1,396-922
Comprehensive Income & Other
13910050--1
Shareholders' Equity
2,4192,7562,5423,2023,7691,900
Total Liabilities & Equity
3,6014,2663,5184,2144,8152,646

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,0861,311852913907567
Net Cash (Debt)
1,9912,4152,2002,9603,5301,846
Net Cash Growth
-20.26%9.77%-25.68%-16.15%91.22%19.48%
Net Cash Per Share
200.56274.37273.27378.891323.283688.31
Filing Date Shares Outstanding
10.099.628.147.836.440.5
Total Common Shares Outstanding
10.099.628.147.836.440.5
Working Capital
2,3723,0682,5923,3213,8832,172
Book Value Per Share
239.67286.63312.31409.12585.093796.20
Tangible Book Value
2,4172,7532,5383,1983,7641,896
Tangible Book Value Per Share
239.47286.31311.82408.60584.313788.21